Breast Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Breast Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 3 (2006), Issue 1 (January)

1. Isoform specific changes in PPAR alpha and beta in colon and breast cancer with differentiation.
   Biochem Biophys Res Commun, 340(2): 656-60. [Abstract] [Full-text]
2. Survival effects of postmastectomy adjuvant radiation therapy using biologically equivalent doses: a clinical perspective.
   J Natl Cancer Inst, 98(1): 26-38. [Abstract] [Full-text]
3. IARC monographs program on carcinogenicity of combined hormonal contraceptives and menopausal therapy.
   Climacteric, 8(4): 311-6. [Abstract] [Full-text]
4. Antitumor benzothiazoles. 26.(1) 2-(3,4-dimethoxyphenyl)-5-fluorobenzothiazole (GW 610, NSC 721648), a simple fluorinated 2-arylbenzothiazole, shows potent and selective inhibitory activity against lung, colon, and breast cancer cell lines.
   J Med Chem, 49(1): 179-85. [Abstract] [Full-text]
5. Use of border information in the classification of mammographic masses.
   Phys Med Biol, 51(2): 425-41. [Abstract] [Full-text]
6. EZH2 expression is associated with high proliferation rate and aggressive tumor subgroups in cutaneous melanoma and cancers of the endometrium, prostate, and breast.
   J Clin Oncol, 24(2): 268-73. [Abstract] [Full-text]
7. Dexamethasone stimulation of retinoic Acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells.
   J Clin Endocrinol Metab, 91(1): 69-78. [Abstract] [Full-text]
8. Social inequalities in breast cancer mortality among French women: disappearing educational disparities from 1968 to 1996.
   Br J Cancer, 94(1): 152-5. [Abstract] [Full-text]
9. Macrophages promote angiogenesis in human breast tumour spheroids in vivo.
   Br J Cancer, 94(1): 101-7. [Abstract] [Full-text]
10. Effects of specialisation on treatment and outcomes in screen-detected breast cancers in Wales: cohort study.
    Br J Cancer, 94(1): 36-42. [Abstract] [Full-text]
11. Role of mammography screening as a predictor of survival in postmenopausal breast cancer patients.
    Br J Cancer, 94(1): 147-51. [Abstract] [Full-text]
12. The measurement and therapeutic implications of circulating tumour cells in breast cancer.
    Br J Cancer, 94(1): 8-12. [Abstract] [Full-text]
13. Factors associated with emotional and behavioural problems among school age children of breast cancer patients.
    Br J Cancer, 94(1): 43-50. [Abstract] [Full-text]
14. Current management of treatment-induced bone loss in women with breast cancer treated in the United Kingdom.
    Br J Cancer, 94(1): 30-5. [Abstract] [Full-text]
15. A twist for survival and cancer progression.
    Br J Cancer, 94(1): 13-7. [Abstract] [Full-text]
16. Birth outcome in women with breast cancer.
    Br J Cancer, 94(1): 142-6. [Abstract] [Full-text]
17. Minimal clinical benefit of single agent Orathecin (Rubitecan) in heavily pretreated metastatic breast cancer.
    Cancer Chemother Pharmacol, 57(4): 540-4. [Abstract] [Full-text]
18. Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells.
    Cancer Chemother Pharmacol, 57(4): 491-9. [Abstract] [Full-text]
19. Unilateral anterior uveitis complicating zoledronic acid therapy in breast cancer.
    BMC Cancer, 5: 156. [Abstract] [Full-text]
20. Mutant p53 gain of function: reduction of tumor malignancy of human cancer cell lines through abrogation of mutant p53 expression.
    Oncogene, 25(2): 304-9. [Abstract] [Full-text]
21. Inhibition of BRCA1 in breast cell lines causes the centrosome duplication cycle to be disconnected from the cell cycle.
    Oncogene, 25(2): 298-303. [Abstract] [Full-text]
22. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Oncogene, 25(2): 230-9. [Abstract] [Full-text]
23. Breast cancer, menopause, and long-term survivorship: critical issues for the 21st century.
    Am J Med, 118(12): 136-41. [Abstract] [Full-text]
24. Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
    J Natl Cancer Inst, 98(2): 116-22. [Abstract] [Full-text]
25. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
    J Natl Cancer Inst, 98(2): 110-5. [Abstract] [Full-text]
26. Multicycle dose-intensive chemotherapy for women with high-risk primary breast cancer: results of International Breast Cancer Study Group Trial 15-95.
    J Clin Oncol, 24(3): 370-8. [Abstract] [Full-text]
27. The use of radiation as a component of breast conservation therapy in National Comprehensive Cancer Network Centers.
    J Clin Oncol, 24(3): 361-9. [Abstract] [Full-text]
28. Assessing BRCA carrier probabilities in extended families.
    J Clin Oncol, 24(3): 354-60. [Abstract] [Full-text]
29. Correlates of return to work for breast cancer survivors.
    J Clin Oncol, 24(3): 345-53. [Abstract] [Full-text]
30. Randomized trial comparing axillary clearance versus no axillary clearance in older patients with breast cancer: first results of International Breast Cancer Study Group Trial 10-93.
    J Clin Oncol, 24(3): 337-44. [Abstract] [Full-text]
31. Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast.
    Cancer Res, 66(2): 1241-9. [Abstract] [Full-text]
32. Tagging single-nucleotide polymorphisms in antioxidant defense enzymes and susceptibility to breast cancer.
    Cancer Res, 66(2): 1225-33. [Abstract] [Full-text]
33. Induction of metastasis by S100P in a rat mammary model and its association with poor survival of breast cancer patients.
    Cancer Res, 66(2): 1199-207. [Abstract] [Full-text]
34. Tumor cells transduced with the MHC class II Transactivator and CD80 activate tumor-specific CD4+ T cells whether or not they are silenced for invariant chain.
    Cancer Res, 66(2): 1147-54. [Abstract] [Full-text]
35. RNA interference-mediated depletion of phosphoinositide 3-kinase activates forkhead box class O transcription factors and induces cell cycle arrest and apoptosis in breast carcinoma cells.
    Cancer Res, 66(2): 1062-9. [Abstract] [Full-text]
36. Farnesyl and geranylgeranyl transferase inhibitors induce G1 arrest by targeting the proteasome.
    Cancer Res, 66(2): 1040-51. [Abstract] [Full-text]
37. The single nucleotide polymorphism IVS1+309 in mouse double minute 2 does not affect risk of familial breast cancer.
    Cancer Res, 66(2): 646-8. [Abstract] [Full-text]
38. Essential role for Rac in heregulin beta1 mitogenic signaling: a mechanism that involves epidermal growth factor receptor and is independent of ErbB4.
    Mol Cell Biol, 26(3): 831-42. [Abstract] [Full-text]
39. C-KIT expression in ductal carcinoma in situ of the breast: co-expression with HER-2/neu.
    Hum Pathol, 37(2): 205-11. [Abstract] [Full-text]
40. Ethanol-induced oxidative stress and acetaldehyde formation in rat mammary tissue: potential factors involved in alcohol drinking promotion of breast cancer.
    Toxicology, 219(1): 208-19. [Abstract] [Full-text]
41. Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer.
    Biochem Biophys Res Commun, 341(1): 73-81. [Abstract] [Full-text]
42. Axillary recurrence in women with a negative sentinel lymph node and no axillary dissection in breast cancer.
    J Surg Oncol, 93(2): 129-32. [Abstract] [Full-text]
43. Radiofrequency ablation of small breast cancer followed by surgical resection.
    J Surg Oncol, 93(2): 120-8. [Abstract] [Full-text]
44. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    J Surg Oncol, 93(2): 109-19. [Abstract] [Full-text]
45. Breast lesions: evaluation with US strain imaging--clinical experience of multiple observers.
    Radiology, 238(2): 425-37. [Abstract] [Full-text]
46. Dynamic contrast-enhanced breast MR imaging in men: preliminary results.
    Radiology, 238(2): 438-45. [Abstract] [Full-text]
47. Impact of a national external quality assessment scheme for breast pathology in the UK.
    J Clin Pathol, 59(2): 138-45. [Abstract] [Full-text]
48. The NHS breast screening programme (pathology) EQA: experience in recent years relating to issues involved in individual performance appraisal.
    J Clin Pathol, 59(2): 130-7. [Abstract] [Full-text]
49. Women with cerebral palsy and breast cancer screening by mammography.
    Arch Phys Med Rehabil, 87(2): 304-7. [Abstract] [Full-text]
50. Dietary and lifestyle determinants of mammographic breast density. A longitudinal study in a Mediterranean population.
    Int J Cancer, 118(7): 1782-9. [Abstract] [Full-text]
51. HER2 amplification in recurrent breast cancer following breast-conserving therapy correlates with distant metastasis and poor survival.
    Int J Cancer, 118(7): 1743-9. [Abstract] [Full-text]
52. Dietary carbohydrate, fibre, glycaemic index, glycaemic load and the risk of postmenopausal breast cancer.
    Int J Cancer, 118(7): 1843-7. [Abstract] [Full-text]
53. Heparanase promotes growth, angiogenesis and survival of primary breast tumors.
    Int J Cancer, 118(7): 1609-17. [Abstract] [Full-text]
54. Optimal selection of individuals for BRCA mutation testing: a comparison of available methods.
    J Clin Oncol, 24(4): 707-15. [Abstract] [Full-text]
55. Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell.
    J Clin Oncol, 24(4): 700-6. [Abstract] [Full-text]
56. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status.
    J Clin Oncol, 24(4): 675-80. [Abstract] [Full-text]
57. Results of the National Initiative for Cancer Care Quality: how can we improve the quality of cancer care in the United States?
    J Clin Oncol, 24(4): 626-34. [Abstract] [Full-text]
58. Optimizing locoregional control and survival for women with breast cancer: a review of current developments in postmastectomy radiotherapy.
    Expert Rev Anticancer Ther, 6(2): 205-16. [Abstract] [Full-text]
59. Cost-effective treatment options in first-line therapy for advanced breast cancer in Japan.
    Expert Rev Anticancer Ther, 6(2): 197-204. [Abstract] [Full-text]
60. BRCA1-associated complexes: new targets to overcome breast cancer radiation resistance.
    Expert Rev Anticancer Ther, 6(2): 187-96. [Abstract] [Full-text]

© 2004-2008 Breast Cancer Research Today. All Rights Reserved.